Results 201 to 210 of about 67,076 (344)

Portal-systemic shunting for metabolic disease [PDF]

open access: yes, 1985
Iwatsuki, S, Porter, KA, Starzl, TE
core  

Progressive development of renal cysts in glycogen storage disease type I.

open access: yesHuman Molecular Genetics, 2016
M. Gjorgjieva   +14 more
semanticscholar   +1 more source

Entomopathogenic Nematodes Induce Metabolic Reallocation in Maize Roots Without Altering the Performance of Two Root Herbivores, Diabrotica virgifera and Diabrotica balteata

open access: yesPlant, Cell &Environment, EarlyView.
ABSTRACT Entomopathogenic nematodes (EPNs) are key biological control agents in agriculture, but their direct effects on plant metabolism and resistance to herbivory remain underexplored. By combining transcriptomic, metabolomic, and herbivore assays, this study aimed at providing a holistic description of maize root responses to EPNs and to assess ...
Arletys M. Verdecia‐Mogena   +7 more
wiley   +1 more source

Genetic risk variants implicate impaired maintenance and repair of periodontal tissues as causal for periodontitis—A synthesis of recent findings

open access: yesPeriodontology 2000, EarlyView.
AbstractPeriodontitis is a complex inflammatory disease in which the host genome, in conjunction with extrinsic factors, determines susceptibility and progression. Genetic predisposition is the strongest risk factor in the first decades of life. As people age, chronic exposure to the periodontal microbiome puts a strain on the proper maintenance of ...
Arne S. Schaefer   +4 more
wiley   +1 more source

Saline‐based modified del Nido cardioplegia versus multidose St. Thomas cardioplegia in canine mitral valve repair: A randomized controlled trial

open access: yesVeterinary Surgery, EarlyView.
Abstract Objective To compare the utility of a saline‐based modified del Nido (mDN) cardioplegia solution with a conventional institutional technique (multidose St. Thomas blood cardioplegia) for mitral valve repair (MVR) in dogs. Study design Prospective, randomized, open‐label trial.
Kentaro Kurogochi   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy